Creatinine kinase isoenzyme-MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy


Bozbay M., Uyarel H., Avsar S., Oz A., Keskin M., Tanik V. O. , ...Daha Fazla

JOURNAL OF CRITICAL CARE, cilt.30, sa.6, ss.1179-1183, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Konu: 6
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.jcrc.2015.07.014
  • Dergi Adı: JOURNAL OF CRITICAL CARE
  • Sayfa Sayıları: ss.1179-1183

Özet

Background: Creatinine kinase isoenzyme-MB(CK-MB) is a biomarker for detecting myocardial injury. The aim of this study was to evaluate the association between admission CK-MB levels and in-hospital and long-term clinical outcomes in pulmonary embolism(PE) patients treated with thrombolytic tissue-plasminogen activator.